Lemaitre Vascular (LMAT) Gains from Investment Securities (2017 - 2024)
Lemaitre Vascular's (LMAT) quarterly Gains from Investment Securities came in at $64000.0 in Q4 2024, up 320.69% year-on-year from $15213.1 in Q1 2024, and up 166.67% on a QoQ basis from $24000.0 in Q3 2024.
Lemaitre Vascular (LMAT) Gains from Investment Securities (2017 - 2024) Analysis & Trends
Lemaitre Vascular (LMAT) has 8 years of Gains from Investment Securities data on file, last reported at $64000.0 in Q4 2024.
- On a quarterly basis, Gains from Investment Securities rose 320.69% year-over-year to $64000.0 in Q4 2024; TTM through Sep 2025 was $64000.0, a 56.1% increase from a year earlier, with the FY2024 full-year figure at $134000.0, up 271.79% from the prior year.
- Gains from Investment Securities for Q4 2024 stood at $64000.0, up from $24000.0 in the prior quarter.
- Over the last five years, Gains from Investment Securities for LMAT reached as high as $64000.0 in Q1 2020 and fell as low as -$48.0 billion in Q3 2020.
- Historically, Gains from Investment Securities has averaged -$2.4 billion across 5 years, with a median of $23000.0 in 2023.
- Across the five-year window, Gains from Investment Securities plunged 109091009.09% in 2020 and soared 320.69% in 2024, its largest moves.
- Year by year, Gains from Investment Securities stood at $50000.0 in 2020, then slumped by 540.0% to -$220000.0 in 2021, then jumped by 54.55% to -$100000.0 in 2022, then jumped by 71.0% to -$29000.0 in 2023, then surged by 320.69% to $64000.0 in 2024.
- Per Business Quant data, the three most recent Gains from Investment Securities figures were $64000.0 in Q4 2024, $24000.0 in Q3 2024, and $23000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 125.97 Bn | 120.75 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.74 Bn | 43.93 Bn | 2.15 Bn |
| 3 | Alcon | 32.94 Bn | 31.28 Bn | 1.53 Bn |
| 4 | Medline | 32.85 Bn | 30.61 Bn | 1.84 Bn |
| 5 | Resmed | 29.46 Bn | 27.80 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.60 Bn | 23.16 Bn | 329.20 Mn |
| 7 | Solventum | 13.99 Bn | 13.43 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.76 Bn | 13.62 Bn | 735.40 Mn |
| 9 | Align Technology | 12.06 Bn | 11.00 Bn | 736.59 Mn |
| 10 | Lemaitre Vascular | 2.25 Bn | 1.88 Bn | 48.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 64,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | -29,000.00 |
| Dec 31, 2023 | -29,000.00 |
| Sep 30, 2023 | -100,000.00 |
| Sep 30, 2023 | -100,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 23,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Dec 31, 2022 | -100,000.00 |
| Dec 31, 2022 | -100,000.00 |
| Sep 30, 2022 | -27,000.00 |
| Sep 30, 2022 | -27,000.00 |